Clinical trials
Clinical Trials clinical trials
Below are recruiting clinical trials clinical trials, each written for real people, not researchers. We’re tracking 1,081 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06573489RecruitingPhase 4
Fospropofol for laparoscopic surgery safety study
This trial tests a sedative called fospropofol during laparoscopic abdominal surgery. It aims to see if it's safe and effective for adults with longer operations.
Wuhan, HubeiAges 18–65 - NCT06578078RecruitingPhase 3
Best heart failure care for older patients with kidney disease
This study tests the best way to manage heart failure in older adults who also have kidney problems and high potassium levels. It compares different treatment strategies to see which one is safest and most effective.
Alcorcón, MadridAges 70 years+ - NCT06578650Recruiting
Restrata Mat for Skin Cancer Surgery Wounds
This study tests a special fiber mat called Restrata that is placed in the wound after skin cancer removal to help it heal. The mat acts as a scaffold for new skin growth and may help close the wound without needing a skin graft.
Las Vegas, NevadaAges 18 years+ - NCT06579417Recruiting
Testing a faster MRI for prostate cancer detection
This trial is testing a new, faster type of MRI scan (called biparametric MRI) to see if it can detect prostate cancer as well as the standard scan. It may help you avoid a longer scan and possibly reduce the need for contrast dye.
San Diego, CaliforniaAges 18 years+ - NCT06581419RecruitingPhase 1/Phase 2
Testing IAP0971 in advanced solid tumors and lung cancer
This trial tests a new drug called IAP0971 for people with advanced solid tumors or a specific type of lung cancer. It may help if your cancer has not responded to other treatments or if you have PD-L1-positive lung cancer that hasn't been treated yet.
Beijing, Beijing MunicipalityAges 18–75 - NCT06583993RecruitingEarly Phase 1
Gene Therapy for Advanced Bile Duct Cancer
This early-phase trial tests a new kind of gene therapy (called HNF4α srRNA) given through a vein for people with advanced intrahepatic cholangiocarcinoma, a type of liver cancer that has stopped responding to standard chemotherapy. The goal is to see if it is safe and if it can help slow or stop the cancer.
Shanghai, Shanghai MunicipalityAges 18 years+ - NCT06586749Recruiting
Nurse-led education and phone support to reduce infections after heart bypass
This study tests whether a special nurse-led program of phone calls and education can help reduce infections after heart bypass surgery. You may be eligible if you are at higher risk for infection and have a smartphone.
Heraklion, CreteAges 18 years+ - NCT06589609RecruitingPhase 1
FluBHPVE6E7 immunotherapy for HPV16-positive oropharyngeal cancer
This trial tests a new immunotherapy called FluBHPVE6E7 for people with HPV16-positive oropharyngeal cancer that has not spread to distant parts of the body. The treatment is given directly into the tumor to help the immune system fight the cancer.
ViennaAges 18–65 - NCT05543330RecruitingPhase 1/Phase 2
M701 for lung cancer with pleural effusion
This trial tests a new drug called M701 for people with non-small cell lung cancer that has spread to the lining of the lung, causing fluid buildup (pleural effusion). It aims to see if M701 can help control the fluid and improve symptoms.
Hangzhou, ZhejiangAges 18–75 - NCT06979180Recruiting
Papillex study for abnormal cervical cells from HPV
This trial tests whether Papillex, a supplement, can help clear abnormal cervical cells caused by HPV. You may be eligible if you have HPV and abnormal cell changes that haven't been treated recently.
London, OntarioAges 25–55 - NCT07485725Recruiting
Digital tools study for health decisions
This study tests if digital tools can help older adults make better healthcare decisions. You’ll use a website to search for health information and share your thoughts in interviews.
Tallahassee, FloridaAges 60 years+ - NCT07644169Recruiting
How your body processes propylene glycol in beverages
This study measures how your body absorbs and eliminates propylene glycol, a common ingredient in many foods and drinks. Researchers want to understand if it's safe and how it moves through your system in healthy adults.
London, OntarioAges 18 years+ - NCT07564661Recruiting
Exercise Recovery Drink Study for Active Adults
This study tests two new drink products designed to help your body rehydrate better after exercise. Researchers will compare how well these drinks work compared to a standard option by having you do exercise challenges and measuring your hydration levels.
London, OntarioAges 18–65 - NCT07509892RecruitingPhase 2
Testing TQH3906 for people with active lupus
This study tests a new medicine, TQH3906, in people with systemic lupus erythematosus (SLE) who have moderate to severe disease activity. It aims to see if TQH3906 can safely reduce lupus symptoms like joint pain, skin rash, or vasculitis.
Bengbu, AnhuiAges 18–74 - NCT06797986RecruitingPhase 1/Phase 2
Vaccine for HPV-positive head and neck cancer
This trial tests an investigational vaccine called BVAC-E6E7 for head and neck cancer caused by HPV types 16 or 18 that has come back or spread. It is for people who have already tried standard treatments like platinum chemo or immunotherapy, or can't take them.
SeoulAges 19 years+ - NCT07034794Recruiting
Lysoveta for memory in healthy adults with mild memory concerns
This study tests whether a supplement called Lysoveta can help with memory and thinking in healthy adults who have mild memory problems. You would take the supplement or a placebo daily for several weeks and visit a clinic for memory tests and questionnaires.
London, OntarioAges 50–75 - NCT06612632RecruitingPhase 1/Phase 2
Retrying Immunotherapy for Solid Tumors After First Trial
This trial tests whether giving immunotherapy again can help people with solid tumors who have already tried an experimental treatment in a clinical trial and it stopped working. It looks for patients whose cancer has returned or spread and who can start the new treatment within 12 weeks of their last therapy.
BeijingAges 18 years+ - NCT06615167Recruiting
Testing ALZGUARD app for diagnosing dementia
This trial tests an app called ALZGUARD that helps doctors diagnose major neurocognitive disorders (like dementia). If you are between 55 and 85 years old, you may be able to help see if the app works well and is safe.
Chuncheon, Gangwon-doAges 55–85 - NCT06617715RecruitingPhase 3
Pneumonia vaccine trial for infants and children
This trial tests a 13-valent pneumococcal conjugate vaccine to prevent pneumonia and serious infections caused by pneumococcus bacteria. It may be a good option if your child has never had a pneumococcal vaccine before.
Zhengzhou, HenanAges 1 month–5 years - NCT06621173RecruitingEarly Phase 1
Gene therapy for advanced colorectal cancer (dMMR/MSI-H)
This trial tests a new gene therapy (HNF4α SrRNA) given through a vein for people with advanced colorectal cancer that has a specific genetic marker (dMMR or MSI-H). It's for those who have already tried standard treatments without success or couldn't take them.
Shanghai, Shanghai MunicipalityAges 18 years+ - NCT06625112Recruiting
STXBP1 disorder clinical trial readiness study
This study is for people with a confirmed STXBP1 genetic change to help prepare for future clinical trials. It collects information about the condition to better understand it.
AntwerpAges Any age - NCT06629389RecruitingPhase 2
Cannabidiol (Kanbis) for Parkinson's symptoms
This trial tests whether cannabidiol (CBD) can help with Parkinson's disease symptoms. Researchers want to see if it's safe and effective for people with mild to moderate Parkinson's who are already on stable medications.
Mendoza, Mendoza ProvinceAges 40–80 - NCT06631209Recruiting
TMS for Better Sleep in Insomnia
This study tests whether a non-invasive brain stimulation technique called transcranial magnetic stimulation (TMS) can improve sleep in people with moderate to severe insomnia. You would come to the University of Arizona for several sessions, and the treatment is painless and doesn't require surgery.
Tucson, ArizonaAges 18–60 - NCT06632964RecruitingPhase 1
Testing VT-101 for non-muscle invasive bladder cancer
This study tests a new drug called VT-101 for people with a type of bladder cancer that hasn't spread into the muscle wall. The goal is to see if the drug is safe and effective. It might be an option if you have already had a biopsy and are not eligible for or refuse surgery.
Xuzhou, JiangsuAges 18–75
Hear when a new Clinical Trials trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for clinical trials?
- Yes. Clin2 currently lists 1,081 recruiting clinical trials studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a clinical trials trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a clinical trials trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
- Clinical Stage IV Cutaneous Melanoma AJCC v8
- Clinical Competence
- Clinical High Risk for Psychosis (CHR)
- Clinical Stage III Cutaneous Melanoma AJCC v8
- Clinical Stage III Gastric Cancer AJCC v8
- Clinical Stage III Esophageal Adenocarcinoma AJCC v8
- Clinical Stage IV Gastric Cancer AJCC v8
- Clinical Decision Support
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.